Juliana Goldbaum Crescente1,2, Alessandra Dellavance3,4, Marcio Augusto Diniz5, Flair Jose Carrilho1, Luis Eduardo Coelho de Andrade3,4, Eduardo Luiz Rachid Cançado1,2. 1. Departamento de Gastroenterologia, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR. 2. Laboratorio de Investigacao Medica (LIM 06), Instituto de Medicina Tropical, Universidade de Sao Paulo, Sao Paulo, SP, BR. 3. Disciplina de Reumatologia, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP, BR. 4. Divisao de Pesquisa e Desenvolvimento, Laboratorios Fleury Medicina e Saude, Sao Paulo, SP, BR. 5. Biostatistics and Bioinformatics Research Center, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Abstract
OBJECTIVES: To determine the frequency of the antineutrophil cytoplasmic antibodies (ANCA), antiproteinase-3 and antimyeloperoxidase, in primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD+ or IBD-) and in different types of autoimmune hepatitis (AIH). Additionally, to verify the agreement between ANCA patterns by indirect immunofluorescence and their antigenic specificities by ELISA. METHODS: For this study, 249 patients were enrolled (42 PSC/IBD+; 33 PSC/IBD-; 31 AIH type-1; 30 AIH type-2; 31 AIH type-3; 52 primary biliary cirrhosis; 30 healthy controls) whose serum samples were tested for ANCA autoantibodies. RESULTS: There were fewer female subjects in the PSC/IBD- group (p=0.034). Atypical perinuclear-ANCA was detected more frequently in PSC/IBD+ patients than in PSC/IBD- patients (p=0.005), and was significantly more frequent in type-1 (p<0.001) and type-3 AIH (p=0.012) than in type-2 AIH. Proteinase-3-ANCA was detected in 25 samples (only one with cytoplasmic-ANCA pattern), and more frequently in PSC/IBD+ than in PSC/IBD- patients (p=0.025). Myeloperoxidase-ANCA was identified in eight samples (none with the perinuclear-ANCA pattern). Among the 62 reactive samples for atypical perinuclear-ANCA, 13 had antigenic specific reactions for proteinase-3 and myeloperoxidase. CONCLUSIONS: PSC/IBD+ differed from PSC/IBD- in terms of sex and proteinase 3-ANCA and atypical perinuclear-ANCA reactivity, the latter of which was more frequently detected in type-1 and type-3 AIH than in type-2 AIH. There was no agreement between ANCA patterns and antigenic specificities in IBD and autoimmune liver diseases, which reinforces the need for proteinase-3 and myeloperoxidase antibody testing.
OBJECTIVES: To determine the frequency of the antineutrophil cytoplasmic antibodies (ANCA), antiproteinase-3 and antimyeloperoxidase, in primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD+ or IBD-) and in different types of autoimmune hepatitis (AIH). Additionally, to verify the agreement between ANCA patterns by indirect immunofluorescence and their antigenic specificities by ELISA. METHODS: For this study, 249 patients were enrolled (42 PSC/IBD+; 33 PSC/IBD-; 31 AIH type-1; 30 AIH type-2; 31 AIH type-3; 52 primary biliary cirrhosis; 30 healthy controls) whose serum samples were tested for ANCA autoantibodies. RESULTS: There were fewer female subjects in the PSC/IBD- group (p=0.034). Atypical perinuclear-ANCA was detected more frequently in PSC/IBD+ patients than in PSC/IBD- patients (p=0.005), and was significantly more frequent in type-1 (p<0.001) and type-3 AIH (p=0.012) than in type-2 AIH. Proteinase-3-ANCA was detected in 25 samples (only one with cytoplasmic-ANCA pattern), and more frequently in PSC/IBD+ than in PSC/IBD- patients (p=0.025). Myeloperoxidase-ANCA was identified in eight samples (none with the perinuclear-ANCA pattern). Among the 62 reactive samples for atypical perinuclear-ANCA, 13 had antigenic specific reactions for proteinase-3 and myeloperoxidase. CONCLUSIONS: PSC/IBD+ differed from PSC/IBD- in terms of sex and proteinase 3-ANCA and atypical perinuclear-ANCA reactivity, the latter of which was more frequently detected in type-1 and type-3 AIH than in type-2 AIH. There was no agreement between ANCA patterns and antigenic specificities in IBD and autoimmune liver diseases, which reinforces the need for proteinase-3 and myeloperoxidase antibody testing.
Authors: Diego Vergani; Fernando Alvarez; Francesco B Bianchi; Eduardo L R Cançado; Ian R Mackay; Michael P Manns; Mikio Nishioka; Edward Penner Journal: J Hepatol Date: 2004-10 Impact factor: 25.083
Authors: D Zauli; S Ghetti; A Grassi; C Descovich; F Cassani; G Ballardini; L Muratori; F B Bianchi Journal: Hepatology Date: 1997-05 Impact factor: 17.425
Authors: Michael Mahler; Jan Damoiseaux; Vera Ballet; Doreen Dillaerts; Chelsea Bentow; Jan-Willem Cohen Tervaert; Daniel Blockmans; Guy Boeckxstaens; Javier Aguilera-Lizarraga; Elena Csernok; Severine Vermeire; Xavier Bossuyt Journal: Clin Chem Lab Med Date: 2017-11-27 Impact factor: 3.694
Authors: Jan Damoiseaux; Elena Csernok; Niels Rasmussen; Frank Moosig; Pieter van Paassen; Bo Baslund; Pieter Vermeersch; Daniel Blockmans; Jan-Willem Cohen Tervaert; Xavier Bossuyt Journal: Ann Rheum Dis Date: 2016-08-01 Impact factor: 19.103
Authors: Johannes R Hov; Kirsten M Boberg; Eli Taraldsrud; Mette Vesterhus; Maria Boyadzhieva; Inger Camilla Solberg; Erik Schrumpf; Morten H Vatn; Benedicte A Lie; Øyvind Molberg; Tom H Karlsen Journal: Liver Int Date: 2016-09-13 Impact factor: 5.828
Authors: Guillermo Muñoz-Sánchez; Albert Pérez-Isidro; Iñaki Ortiz de Landazuri; Antonio López-Gómez; Luz Yadira Bravo-Gallego; Milagros Garcia-Ormaechea; Maria Rosa Julià; Odette Viñas; Estíbaliz Ruiz-Ortiz Journal: Diagnostics (Basel) Date: 2022-03-12